Name,Alias,Ab or Nb,Protein+Epitope,Epitope class,Binds to,Not Bind to,Neutralising Vs,Not Neutralising Vs,SPR RBD (KD; nm),SPR S1 (KD; nm),SPR S2 (KD; nm),SPR S-ECD (KD; nm),SPR S (KD; nm),SPR NTD (KD; nm),SPR N (KD; nm),BLI RBD (KD; nm),BLI S1 (KD; nm),BLI S (KD; nm),BLI NTD (KD; nm),BLI N (KD; nm),MST RBD (KD; nm),ELISA RBD competitive (IC50; ¦Ìg/ml),ELISA S1 competitive (IC50; ¦Ìg/ml),ELISA S competitive (IC50; ¦Ìg/ml),ELISA S competitive (IC80; ¦Ìg/ml),ELISA NTD competitive (IC50; ¦Ìg/ml),ELISA RBD binding (EC50; ¦Ìg/ml),ELISA S1 binding (EC50; ¦Ìg/ml),ELISA S binding (EC50; ¦Ìg/ml),ELISA N binding (EC50; ¦Ìg/ml),FACS RBD (IC50; nm/ml),FACS S (IC50; nm/ml),Live Virus Neutralisation IC50 (50% titre; ¦Ìg/ml)ãÐÖµ2¦Ìg/ml,Live Virus Neutralisation IC80 (80% titre; ¦Ìg/ml),Live Virus Neutralisation IC90 (90% titre; ¦Ìg/ml),Live Virus Neutralisation IC100 (100% titre; ¦Ìg/ml),Pseudo Virus Neutralisation IC50 (50% titre; ¦Ìg/ml),Pseudo Virus Neutralisation IC80 (80% titre; ¦Ìg/ml),Pseudo Virus Neutralisation IC90 (90% titre; ¦Ìg/ml),Pseudo Virus Neutralisation IC100 (100% titre; ¦Ìg/ml),Pseudo Virus Neutralisation (fold change),Source,Source-update,Notes,Origin,VH or VHH,VL,Heavy V Gene,Heavy J Gene,Light V Gene,Light J Gene,CDRH3,CDRL3,PDB
C110,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Beta;SARS-CoV2_Mu (weak),SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1;SARS-CoV1,SARS-CoV2_WT;SARS-CoV2_Beta (weak);SARS-CoV2_Mu (weak),SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1;SARS-CoV1,0.156;24.4(Mu);NA(C.1.2)£»NA(Omicron)[Bin Ju et al.£» 2022] && 1.3;68(R346K);8(N439K);2(N440K);3(A475V);2(V483A);27(E484K);12(Q493R)[Christopher Barnes],,,,,,,,,,,,,,,,,,0.0072889999999999995[Davide Robbiani et al.£» 2020],,,,,,0.0184[Christopher Barnes],,0.0773[Christopher Barnes],,0.005;7.235(Beta);>50(Delta);6.787(Mu);>50(C.1.2);>50(Omicron);[Bin Ju et al.£» 2022] && 0.01844288847917425[Davide Robbiani et al.£» 2020],0.045110196996549855[Davide Robbiani et al.£» 2020],0.07728268534851881[Davide Robbiani et al.£» 2020],,,Bin Ju et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.01.19.476892v1) && Christopher Barnes (https://www.nature.com/articles/s41586-020-2852-1) && Davide Robbiani et al.£» 2020 (https://www.nature.com/articles/s41586-020-2456-9),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLQQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTISADKSISTAYMQWSSLKASDTAMYYCARSFRDDPRIAVAGPADAFDIWGQGTMVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISYWLAWYQQKPGKAPKLLIYQASSLESGVPSRFSGSESGTEFTLTISSLQPDDFATYYCQQYNSYPYTFGQGTKLEIK,IGHV5-51 (Human),IGHJ3 (Human),IGKV1-5 (Human),IGKJ2 (Human),ARSFRDDPRIAVAGPADAFDI,QQYNSYPYT,https://www.rcsb.org/structure/7K8P; https://www.rcsb.org/structure/7K8V
HbnC2t1p2_D9,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,72,,,,,,,,,,,,,,,,,,,,0.04,,,,0.93,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGRNKYYVDSVKGRFTISRDNSKNTLYLQISSLRAEDTAVYYCARAARRPVVTDTMAYYMDVWGKGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASLSLSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPTWTFGQGTKAEIK,IGHV3-33 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARAARRPVVTDTMAYYMDV,QQRSNWPPTWT,ND
CC12.16,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT (weak),SARS-CoV1,147,,,,,,,,,,,,,0.59,,0.073,,,,,,,,,61,,,,,,,,,Thomas Rogers et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc7520),,Complete. SHM % listed in paper.,B-cells; SARS-CoV2_WT Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVALIWYDGSNKNYADSVKGRFTISRDNSKNTLDLQMNSLRAEDTAVYYCARDPFPGAVAGTGYLQYWGQGTLVTVSS,SYELTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDPWVFGGGTKLTVL,IGHV3-33 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ3 (Human),ARDPFPGAVAGTGYLQY,QVWDSSSDPWV,ND
H014,,Ab,S; RBD,,SARS-CoV1;SARS-CoV2_WT;SARS-CoV2_Beta;SARS-CoV2_Delta;SARS-CoV2_Mu,SARS-CoV2_Omicron-BA1,SARS-CoV1;SARS-CoV2_WT;SARS-CoV2_Beta;SARS-CoV2_Delta;SARS-CoV2_Mu,SARS-CoV2_Omicron-BA1,0.126;0.117(Mu);0.114(C.1.2)£»NA(Omicron)[Bin Ju et al.£» 2022],,,,,,,,,,,,,,,,,,0.7nM[Zhe Lv et al.£» 2020],,,,,,3nM[Zhe Lv et al.£» 2020],,,,0.112;0.689(Beta);0.385(Delta);0.556(Mu);0.098(C.1.2);>50(Omicron);[Bin Ju et al.£» 2022] && 1nM[Zhe Lv et al.£» 2020],,,,,Bin Ju et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.01.19.476892v1) && Yao Sun et al.£» 2021 (https://www.nature.com/articles/s41422-021-00497-7) && Zhe Lv et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.06.02.129098v2),,Complete,Immunised Humanised (hACE2) Mouse,EVQLVQSGAEVKKPGATVKISCKVSGYSFSNYYIHWVKQAPGKSLEWIGYIDPFNGGTSDNLKFKGAATLTADTSTDTAYMELSSLRSEDTAVYYCARSEYDPYYVMDYWGQGTTVTVSS,IVLTQSPFQSVSPKEKVTITCRASQSISSNLHWYQQKPDQSPKLLIKYASQSISGIPSRFSGSGSGTDFTLTINSLEAEDFGIYFCQQTNFWPYIFGQGTKLEIL,IGHV1-69-2 (Mouse),IGHJ6 (Mouse),IGKV6-21 (Mouse),IGKJ2 (Mouse),ARSEYDPYYVMDY,QQTNFWPYI,https://www.rcsb.org/structure/7CAI; https://www.rcsb.org/structure/7CAK; https://www.rcsb.org/structure/7CWN; https://www.rcsb.org/structure/7CAC; https://www.rcsb.org/structure/7E5R; https://www.rcsb.org/structure/7E5S; Expected (7cab and 7cah)
CC12.25,,Ab,S; non-RBD,,SARS-CoV1;SARS-CoV2_WT,,,SARS-CoV1,3.88,,,,,,,,,,,,,,,0.018,,,,,,,,,,,,,,,,,,Thomas Rogers et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc7520),,Complete. SHM % listed in paper.,B-cells; SARS-CoV2_WT Human Patient,QVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGDSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRYYEFWSGYSNWFDPWGQGTLVTISS,QSALTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKVLVYSNDQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGPVFGGGTKLTVL,IGHV3-23 (Human),IGHJ5 (Human),IGLV1-44 (Human),IGLJ3 (Human),AKDRYYEFWSGYSNWFDP,AAWDDSLNGPV,ND
NT-193,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,1.2,,,,,,,0.687,,,,,,,,,,,,,,,,,,,,,,,,,,Taishi Onodera et al.£» (https://www.cell.com/action/showPdf?pii=S1074-7613%2821%2900359-9),,Complete,Immunised mouse (TC-mAb),EVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGWDLDYYYGMDVWGQGTTVTVSS,AIRMTQSPSAMSASVGDRVTVTCRASQGIGNYLAWFQLKPGKVPKRLIYAASSLQSGVPARFSGGGSGTEFTLTISSLQPEDFATYYCLQHGFLPWTFGQGTKLEIK,IGHV4-34 (Human),IGHJ6 (Human),IGKV1-17 (Human),IGKJ1 (Human),ARGWDLDYYYGMDV,LQHGFLPWT,https://www.rcsb.org/structure/7E5O
CC12.28,,Ab,S; RBD,,SARS-CoV1;SARS-CoV2_WT,,SARS-CoV2_WT and SARS-CoV1,,286,,,,,,,,,,,,,0.66,,0.64,,,,,,,,,,,,,0.039,,,,,Thomas Rogers et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc7520),,Complete. SHM % listed in paper.,B-cells; SARS-CoV2_WT Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYAMTWVRQAPGKGLEWVSAISSGSGSTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAIYYCAKANKYSSSEFDFWGQGTLVTISS,QSALTQPPSASGTPGQRVTISCSGSSSNIGSNYVYWYQQLPGAAPKLLIYRNDQRPSGVPDRFSGSKSGTSVSLAISGLRSEDEADYYCAAWDDSLSGWVFGGGTKLTVL,IGHV3-23 (Human),IGHJ4 (Human),IGLV1-47 (Human),IGLJ3 (Human),AKANKYSSSEFDF,AAWDDSLSGWV,ND
DK5,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,0.26[CN111978395A] && 1.31[Lina Jia et al.£» 2021],,,,,,,,,,,,,,,,,,0.188nM[Lina Jia et al.£» 2021],,,,,,0.306nM[Lina Jia et al.£» 2021],,,,0.015[CN111978395A] && 1.84nM[Lina Jia et al.£» 2021],9.2nM[Lina Jia et al.£» 2021],,,,CN111978395A (https://patents.google.com/patent/CN111978395A/en) && Lina Jia et al.£» 2021 (https://onlinelibrary.wiley.com/doi/full/10.1002/mco2.79),,Could be MA2/MA11/MA13/MA14 in paper. Complete,Immunised Mouse,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYSMHWVEKQTPGQGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARDYHYDGYYVTLDYWGQGTTLTVSS,DIQMTQSPSSLSASLGERVSLTCRASQEISGYLSWLQQKPDGTIKRLIYAASTLDSGVPKRFESGSRSGSDYSLTISSLESEDFADYYCLQYASYPWTFGGGTKLEIK,IGHV1-12 (Mouse),IGHJ2 (Mouse),IGKV9-124 (Mouse),IGKJ1 (Mouse),ARDYHYDGYYVTLDY,LQYASYPWT,ND
CV07-262,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,,0.079,,,,,,,,,,,,,,,,,,0.0121,,,,,,0.0071,,,,,,,,,Jakob Kreye et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.08.15.252320v1.full.pdf),Jakob Kreye et al.£» 2020 (https://www.cell.com/cell/fulltext/S0092-8674(20)31246-0),Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQTFQGRVTMTRDTSITTTYMELSRLRSDDTAVYYCARVGWYDFGTPGDYYYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYFCCSYAGTSTFVFGTGTKVTVLGQPKANPTVTL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ1 (Human),ARVGWYDFGTPGDYYYYYGMDV,CSYAGTSTFV,ND
CC6.32,,Ab,S; RBD,,SARS-CoV1;SARS-CoV2_WT,,SARS-CoV2_WT,,1.08,,,,,,,,,,,,,0.013,,0.014,,,,,,,,,3.5,,,,1.1,,,,,Thomas Rogers et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc7520),,Complete. SHM % listed in paper.,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIAFAGSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDQGYSYGNYFDYWGQGTLVTVSS,QLVLTQPPSVSVAPGKTARITCGGNNIGSKSVYWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDHPYVFGSGTKVTVL,IGHV3-9 (Human),IGHJ4 (Human),IGLV3-21 (Human),IGLJ6 (Human),AKDQGYSYGNYFDY,QVWDSSSDHPYV,ND
MnC2t2p1_C11,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,0.02,,,,,,,,,,,,,,,,,,,,0.02,,,,0.25,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSRYTIIWVRQAPGQGLEWMGRIIPILDIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCAREGGLDYFGSRNSGWTYTWFDPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQNISSYLNWYQQKPGKAPNLLIYAASSLQSGVPPRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTLYSFGQGTKLEIK,IGHV1-69 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ2 (Human),AREGGLDYFGSRNSGWTYTWFDP,QQSYSTLYS,ND
32C7_Fab30,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Beta;SARS-CoV2_Delta,,SARS-CoV2_WT;SARS-CoV2_Beta (weak);SARS-CoV2_Delta (weak),,10.9[CN113388030B] && 0.00219[Xiaofei Wang et al.£» 2022],,,,,,,,,,,,,,,,,,0.1038[Xiaofei Wang et al.£» 2022],,,,,,0.004588;0.1276(D614G);1.42(501Y.V2)[CN113388030B] && 0.00459(WT)£»0.1276(D614G)£»1.420(B.1.351)£»3.442(B.1.617.2)[Xiaofei Wang et al.£» 2022],,,,,,,,,CN113388030B (https://patents.google.com/patent/CN113388030B/en) && Xiaofei Wang et al.£» 2022 (https://www.nature.com/articles/s41392-022-00954-8),,Two names: 32C7 and Fab30. Complete,Transgenic Mouse,EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYPMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDTEDCSSTTCYVDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYRSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCHQYYSTPFTFGGGTKVDIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV4-1 (Human),IGKJ3 (Human),ARDTEDCSSTTCYVDY,HQYYSTPFT,https://www.rcsb.org/structure/7ENF;https://www.rcsb.org/structure/7ENG
CV05-163,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,,0.349;NA(Mu);3.47(C.1.2)£»5.58(Omicron)[Bin Ju et al.£» 2022] && 2.49[Rui Shi et al.£» 2020] && 15.1;N.D.(K417N);N.D.(K417T);16.1(L452R);27.2(E484K);16.4(E484Q);85.3(Alpha);N.D.(Beta);N.D.(Gamma);14.4(Kappa)[Fangzhu Zhao et al.£» 2029],,,,,,,45.3[Meng Yuan et al.£» 2021],,,,,,,,,,,0.0038[Jakob Kreye et al.£» 2020],,,,,,0.0163[Jakob Kreye et al.£» 2020] && 0.0163[Meng Yuan et al.£» 2021],,,,,,,,,Jakob Kreye et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.08.15.252320v1.full.pdf) && Meng Yuan et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.02.16.430500v1),Jakob Kreye et al.£» 2020 (https://www.cell.com/cell/fulltext/S0092-8674(20)31246-0),Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCAREVMVRGALPPYGMDVWGQGTTVTVSS,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPVTFGGGTKVEIK,IGHV1-2 (Human),IGHJ6 (Human),IGKV3-11 (Human),IGKJ4 (Human),AREVMVRGALPPYGMDV,QQRSNWPPVT,https://www.rcsb.org/structure/7LOP
CC12.20,,Ab,S; non-RBD,,SARS-CoV2_WT,SARS-CoV1,,SARS-CoV1,2.6,,,,,,,,,,,,,,,0.036,,,,,,,,,,,,,,,,,,Thomas Rogers et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc7520),,Complete. SHM % listed in paper.,B-cells; SARS-CoV2_WT Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMSSLRGEDTAVYYCAKDQAYYDILTGYLNPPKNYYYYGMDVWGQGTTVTVSS,QSVLTQPPSASSTPGQRVTISCSGSSSNIGSNYVYWYQQLPGTAPKLLIYTNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCAAWDDSLSGRVVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV1-47 (Human),IGLJ3 (Human),AKDQAYYDILTGYLNPPKNYYYYGMDV,AAWDDSLSGRVV,ND
MnC2t1p1_A3,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,0.7,,,,,,,,,,,,,,,,,,,,0.05,,,,0.78,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGRGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRPEDTAVYYCATGARFGESPFDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPGTFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1D-12 (Human),IGKJ1 (Human),ATGARFGESPFDY,QQANSFPGT,ND
C144,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Delta,SARS-CoV1;SARS-CoV2_Mu;SARS-CoV2_Omicron-BA1,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Delta,SARS-CoV1;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2-Mu;SARS-CoV2_Omicron-BA1,0.563;NA(Mu);NA(C.1.2)£»NA(Omicron)[Bin Ju et al.£» 2022] && 18;52(R346K);29(N439K);40(N440K);228(A475V);32(V483A);n.b.(E484K);n.b.(Q493R)[Christopher Barnes et al.£» 2020],,,,,,,,,,,,,,,,,,0.0032355[Davide Robbiani et al.£» 2020],,,,,,0.0069[Christopher Barnes et al.£» 2020] && 0.00255[Davide Robbiani et al.£» 2020],,0.0297[Christopher Barnes et al.£» 2020],,0.001;>50(Beta);0.005(Delta);>50(Mu);>50(C.1.2);>50(Omicron);[Bin Ju et al.£» 2022] && 0.006907200800662471[Davide Robbiani et al.£» 2020] && 0.0051(D614G)£»0.0057(B.1.1.7)£»>10.0(B.1.361)£»>10.0(P.1)£»0.0049(B.1.617.2)£»>10.0(B.1.1.529)[Tongqing Zhou et al.£» 2021],0.01728116312342745[Davide Robbiani et al.£» 2020] && 0.0098(D614G)£»0.0224(B.1.1.7)£»>10.0(B.1.361)£»>10.0(P.1)£»0.0206(B.1.617.2)£»>10.0(B.1.1.529)[Tongqing Zhou et al.£» 2021],0.029656007395904554[Davide Robbiani et al.£» 2020],,,Bin Ju et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.01.19.476892v1) && Christopher Barnes et al.£» 2020 (https://www.nature.com/articles/s41586-020-2852-1) && Davide Robbiani et al.£» 2020 (https://www.nature.com/articles/s41586-020-2456-9) && Koen Van Rompay et al.£» 2021 (https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009688) && Tongqing Zhou et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.27.474307v1),,Therapeutic mAb Crexavibart. Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSNNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDKSKNTLYLQMNRLRAEDTAVYYCAREGEVEGYNDFWSGYSRDRYYFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL,IGHV3-53 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ1 (Human),AREGEVEGYNDFWSGYSRDRYYFDY,SSYTSSSTRV,https://www.rcsb.org/structure/7K90
DK15,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,77[CN111978395A] && 260[Lina Jia et al.£» 2021],,,,,,,,,,,,,,,,,,0.127nM[Lina Jia et al.£» 2021],,,,,,,,,,0.191[CN111978395A] && 0.41nM[Lina Jia et al.£» 2021],1.18nM[Lina Jia et al.£» 2021],,,,CN111978395A (https://patents.google.com/patent/CN111978395A/en) && Lina Jia et al.£» 2021 (https://onlinelibrary.wiley.com/doi/full/10.1002/mco2.79),,Also known as MA17 in paper. Complete,Immunised Mouse,QVQLQQPGAEFVMPGASVKMSCKASGYTFTDYWMHWVKQRPGQGLEWIGAIDTSDTYTRYNQKFKDKATLTVDESSSTAYMQLSSLTSEDSAVYYCARFLYYYGNPTFDYWGQGTTLTVSS,DVQITQSPSYLAASPGETITINCRASKSISKYLAWYQEKPGKTNKLLIYSGSTLQSGIPSRFSGSGSGTDFTLTISSLEPEDFAMYYCQQHNEYPLTFGAGTKLELK,IGHV1-69 (Mouse),IGHJ2 (Mouse),IGKV16-104 (Mouse),IGKJ5 (Mouse),ARFLYYYGNPTFDY,QQHNEYPLT,ND
MnC4t1p1_A10,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,520,,,,,,,,,,,,,,,,,,,,0.07,,,,42.04,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,QLQVQESGPGLVKPSETLSLTCTVSGASISSNHYFWGWIRQPPGKGLAWIGSMHYSGSTYYNPSLKSRVTISVDTSKNQLSLKLSSVTAADTAVYYCARGVNYYDRNGYYRNDGFDIRGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYEQKPGKAPKRLIYAASSLESGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNTYPFTFGPGTRVDIK,IGHV4-39 (Human),IGHJ3 (Human),IGKV1-17 (Human),IGKJ3 (Human),ARGVNYYDRNGYYRNDGFDI,LQHNTYPFT,ND
CC12.21,,Ab,S; non-RBD,,SARS-CoV2_WT,SARS-CoV1,,SARS-CoV1,36.2,,,,,,,,,,,,,,,0.005,,,,,,,,,,,,,,,,,,Thomas Rogers et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc7520),,Complete. SHM % listed in paper.,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETIYAQKFQGRVTMTEDTSTDTAYMDLSSLRSEDTAVYYCATAFSIFGVVPPDYWGQGTLVTVS,QAVVTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGPVFGGGTKLTVL,IGHV1-24 (Human),IGHJ4 (Human),IGLV1-44 (Human),IGLJ3 (Human),ATAFSIFGVVPPDY,AAWDDSLNGPV,ND
CV07-209,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,,0.006,,,,,,,,,,,,,,,,,,0.0041,,,,,,0.0031,,,,,,,,,Jakob Kreye et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.08.15.252320v1.full.pdf),Jakob Kreye et al.£» 2020 (https://www.cell.com/cell/fulltext/S0092-8674(20)31246-0),Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSVSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDGVIPPRFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV3-11 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARDGVIPPRFDY,QQYDNLPLT,ND
S304,,Ab,S; RBD,¢òc£»4,SARS-CoV1;SARS-CoV2_WT;SARS-CoV2_Beta;SARS-CoV2_Delta;SARS-CoV2_Mu;SARS-CoV2_Omicron-BA1,,SARS-CoV1;SARS-CoV2_WT (weak);SARS-CoV2_Beta (weak);SARS-CoV2_Delta (weak);SARS-CoV2_Mu (weak),SARS-CoV2_Omicron-BA1,0.0941;0.0772(Mu);0.0365(C.1.2)£»0.21(Omicron)[Bin Ju et al.£» 2022] && 6[Luca Piccoli et al.£» 2020],,,,25[Luca Piccoli et al.£» 2020],,,4.58;0.869(SARS)[Dora Pinto et al.£» 2020],,,,,,,,,,,,,,,,,,,,4.603;>10(Omicron)[Elisabetta Cameroni et al.£» 2021],0.002;0.002(Beta);0.003(Delta);0.001(Mu);0.002(C.1.2);>50(Omicron);[Bin Ju et al.£» 2022] && >5[Luca Piccoli et al.£» 2020],,,,,Bin Ju et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.01.19.476892v1) && Dora Pinto et al.£» 2020 (https://www.nature.com/articles/s41586-020-2349-y) && Elisabetta Cameroni et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.12.472269v1) && Luca Piccoli et al.£» 2020 (https://www.cell.com/cell/fulltext/S0092-8674(20)31234-4) && Matthew McCallum et al.£» 2021 (https://dx.doi.org/10.1126/science.abn8652),,Variant binding data in Starr et al. Complete,B-cells; SARS-CoV1 Human Patient,VQLVESGGGLVQPGGSLRLSCAASGFTFSSYDMHWVRQTTGKGLEWVSTIGTAGDTYYPDSVKGRFTISREDAKNSLYLQMNSLRAGDTAVYYCARGDSSGYYYYFDYWGQGTLLTVSS,DIEMTQSPSSLSAAVGDRVTITCRASQSIGSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFAIYYCQQSYVSPTYTFGPGTKVDIK,IGHV3-13 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ3 (Human),ARGDSSGYYYYFDY,QQSYVSPTYT,https://www.rcsb.org/structure/7JW0;https://www.rcsb.org/structure/7L0N;https://www.rcsb.org/structure/7R6X;https://www.rcsb.org/structure/7TN0
DK10,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,31.2[CN111978395A] && 1.11[Lina Jia et al.£» 2021],,,,,,,,,,,,,,,,,,0.092nM[Lina Jia et al.£» 2021],,,,,,0.088nM[Lina Jia et al.£» 2021],,,,0.245[CN111978395A] && 0.11nM[Lina Jia et al.£» 2021],0.34nM[Lina Jia et al.£» 2021],,,,CN111978395A (https://patents.google.com/patent/CN111978395A/en) && Lina Jia et al.£» 2021 (https://onlinelibrary.wiley.com/doi/full/10.1002/mco2.79),,Complete,Immunised Mouse,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYSMHWVKQTPGQGLEWIGAIYPGNGDTSYTQKEKGKATLTADKSSSTAYMQLNSLTSEDSAVYYCARDYHYDGYYVILDYWGQGTTLTVSS,DIQMTQSPSSLSASLGERVSLTCRASQEISGYLSWLQQKPDGTIKRLIYAASTLDSGVPKRFSGSRSGSDYSLTISSLESEDFADYYCLQYASYPWTFGGGTKLEIK,IGHV1-12 (Mouse),IGHJ2 (Mouse),IGKV9-124 (Mouse),IGKJ1 (Mouse),ARDYHYDGYYVILDY,LQYASYPWT,ND
REGN10954,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,2.38;0.0369(Fc),,,,,,,,,,,,,0.0746nm,,,,,,,,,,,,,,,0.0922nm,,,,,Johanna Hansen et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abd0827),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARDHGMAAAGYNYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDINKYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTINSLQPEDFATYFCQQYDNLPPAFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ1 (Human),ARDHGMAAAGYNY,QQYDNLPPA,ND
DK11,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,5.6[CN111978395A] && 31.2[Lina Jia et al.£» 2021],,,,,,,,,,,,,,,,,,0.086nM[Lina Jia et al.£» 2021],,,,,,,,,,0.051[CN111978395A] && 1.63nM[Lina Jia et al.£» 2021],5.12nM[Lina Jia et al.£» 2021],,,,CN111978395A (https://patents.google.com/patent/CN111978395A/en) && Lina Jia et al.£» 2021 (https://onlinelibrary.wiley.com/doi/full/10.1002/mco2.79),,Also known as MA9 in paper. Complete,Immunised Mouse,EVQLQQSGPELVKPGASVKISCKASGYSFTGYFMNWVKQSHGKSLEWIGRINPYNGDTFYNQKFKGKATLTVDKSSSTAHMELLSLTSEDSAVYYCGRGYLDYWGQGTTLTVSS,DIVMTQSHKFMSTSVGDRVSITCKASQDVSTAVAWYQQKPGQSPKLLIFSASYRYTGVPDRFTGSGSGTDFTFTISSVQAEDLAVYYCQEHYSNPYTFGGGTKLEIK,IGHV1-37 (Mouse),IGHJ2 (Mouse),IGKV6-17 (Mouse),IGKJ2 (Mouse),GRGYLDY,QEHYSNPYT,ND
m338,,Ab,S; RBD,,MERS-CoV,,MERS-CoV,,15.1,,,,,,,,,,,,,0.041,,,,,,,,,,,,,,,,,,,,Tianlei Ying et al.£» 2004 (https://jvi.asm.org/content/88/14/7796),,Complete. Author replied with sequence.,B-cells; MERS-CoV Human Patient,QVQLQQSGAEVKKRGSSVKVSCKASGGTFSSYTISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDLYDSSGYYRNTDAFDIWGQGTMVTVSS,EIVMTQSPVTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV3-11 (Human),IGKJ1 (Human),ARDLYDSSGYYRNTDAFDI,QQYGSSPWT,ND
HbnC3t1p2_B10,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,1,,,,,,,,,,,,,,,,,,,,0.22,,,,0.25,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYFFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLISGASSRAAGIPDRFSGSGSGTDFTLTINRLEPEDFAVYYCQQYGSSPRTFGQGTKLEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDYGDYFFDY,QQYGSSPRT,ND
CC12.15,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,SARS-CoV1,87.9,,,,,,,,,,,,,4.9,,0.87,,,,,,,,,4.5,,,,3.7,,,,,Thomas Rogers et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc7520),,Complete. SHM % listed in paper.,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYEMNWVRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTISRDNAKNSLYLQMSSLRAEDTAIYYCARDRRRRYCTNGVCYRPEEIDYWGQGTLVTVSS,QAVLTQPPSVSGAPGQRVTISCTGSSSNIEAGYDVHWYQQLPGTAPKLLIYVNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGVVFGGGTKLIVL,IGHV3-48 (Human),IGHJ4 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARDRRRRYCTNGVCYRPEEIDY,QSYDSSLSGVV,ND
C002,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,SARS-CoV1,11;27(R346K);16(N439K);24(N440K);31(A475V);11(V483A);n.b.(E484K);596(Q493R)[Christopher Barnes et al.£» 2020],,,,,,,,,,,,,,,,,,0.0031385000000000002[Davide Robbiani et al.£» 2020],,,,,,0.0089[Christopher Barnes et al.£» 2020],,0.0376[Christopher Barnes et al.£» 2020],,0.00888189263957582[Davide Robbiani et al.£» 2020],0.02194810291177685[Davide Robbiani et al.£» 2020],0.03760709568663475[Davide Robbiani et al.£» 2020],,,Christopher Barnes et al.£» 2020 (https://www.nature.com/articles/s41586-020-2852-1) && Davide Robbiani et al.£» 2020 (https://www.nature.com/articles/s41586-020-2456-9),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFSIYGMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKEGRPSDIVVVVAFDYWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKEGRPSDIVVVVAFDY,QQSYSTPRT,https://www.rcsb.org/structure/7K8S; https://www.rcsb.org/structure/7K8T; https://www.rcsb.org/structure/7K8U; https://www.rcsb.org/structure/7K8O
Fab2-15,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Delta,SARS-CoV2_Omicron-BA1;SARS-CoV2_Omicron-BA2,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Delta,SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Omicron-BA1;SARS-CoV2_Omicron-BA2,0.0275[Micah Rapp et al.£» 2021],,,,,,,,,,,,,,,,,,,,,,,,0.0007[Lihong Liu et al.£» 2020] && 0.0007[Micah Rapp et al.£» 2021],,,,0.005[Lihong Liu et al.£» 2020] && 0.005[Micah Rapp et al.£» 2021],,,,+2.2(Alpha);1329(Lota);4.6(Eplison);10(Delta);1329(Gamma);1329(Beta);>1000(Omicron);>1000(Omicron+R346K);+1.1(A67V);1.4(Del69-70);+1.1(T95I);1.6(G142D);+1.5(Del143-145);1.2(Del211);1.3(L212I);4.3(Ins214EPE);1.4(G339D);1.4(R346K);1.4(S371L);1.4(S373P);+2.6(S375F);+1.1(K417N);1.6(N440K);3.0(G446S);1.7(S477N);1.2(T478K);>1000(E484K);705(Q493R);9.3(G496S);1.0(Q498R);1.2(N501Y);+1.1(Y505H);1.7(T547K);8.6(H655Y);1.2(N679K);1.5(P691H);2.1(N764K);1.4(D769Y);1.0(N856K);+1.1(Q954H);1.3(N969K);+1.9(L981F)[Lihong Liu et al.£» 2021],Lihong Liu et al.£» 2020 (https://www.nature.com/articles/s41586-020-2571-7) && Lihong Liu et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.14.472719v3) && Micah Rapp et al.£» 2021 (https://www.cell.com/cell-reports/fulltext/S2211-1247(21)00264-3) && Sho Iketani et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.02.07.479306v1) && Xun Wang et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.24.474138v1),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGASVRVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPISDGTNYAQKFQGWVTMTRDTSISTVYMELSRLRSDDTAVYYCARGGSRCSGGNCYGWAYDAFDIWGQGTMITVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNFVSWYQQHPGKAPKLMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADCYCSSYTSSSTFVFGTGTKVTVL,IGHV1-2 (Human),IGHJ3 (Human),IGLV2-14 (Human),IGLJ1 (Human),ARGGSRCSGGNCYGWAYDAFDI,SSYTSSSTFV,https://www.rcsb.org/structure/7L5B;https://www.rcsb.org/structure/7L57
CC12.10,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,SARS-CoV1;SARS-CoV2_Omicron-BA1,0.349;NA(Mu);3.47(C.1.2)£»5.58(Omicron)[Bin Ju et al.£» 2022] && 2.49[Rui Shi et al.£» 2020] && 15.1;N.D.(K417N);N.D.(K417T);16.1(L452R);27.2(E484K);16.4(E484Q);85.3(Alpha);N.D.(Beta);N.D.(Gamma);14.4(Kappa)[Fangzhu Zhao et al.£» 2024],,,,,,,,,,,,,0.016[Thomas Rogers et al.£» 2020],,0.013[Thomas Rogers et al.£» 2020],,,,,,,,,0.043[Fangzhu Zhao et al.£» 2022] && 0.058[Thomas Rogers et al.£» 2020],,,,0.020;>10(SARS)[Fangzhu Zhao et al.£» 2022] && 0.07[Thomas Rogers et al.£» 2020],,,,,Fangzhu Zhao et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.01.06.475303v1.full.pdf) && Thomas Rogers et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc7520),,Complete. SHM % listed in paper.,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIYSGYFMHWVRQAPGQGLEWMGWISPDSGGANYAQTFQGRVTMTRDTSTTTAHMELSRLRSDDTAVYYCARGPRYSGTHFDYWGQGTLVTVSS,QSALTQPASVSGSPGQSLTISCTGTSSDVGGYNYVSWYQQHPDKAPKLMIYDVNNRPSGVSNRFSGSKSGSTASLTISGLQAEDEADYYCSSYAGSSTQVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPRYSGTHFDY,SSYAGSSTQV,ND
REGN10934,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,4.86;0.0057(Fc),,,0.0371,,,,,,,,,,0.0636nm,,,,,,,,,,,0.0283nm,,,,0.0544nm,,,,,Johanna Hansen et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abd0827),,Complete,B-cells; Transgenic Mouse (VelocImmune),EVQLVESGGGLVKPGGSLRLSCAASGITFSNAWMSWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTARWDWYFDLWGRGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDIWNYINWYQQKPGKAPKLLIYDASNLKTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQHDDLPPTFGQGTKVEIK,IGHV3-15 (Human),IGHJ2 (Human),IGKV1-33 (Human),IGKJ1 (Human),TTARWDWYFDL,QQHDDLPPT,ND
Ab_510A5,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Omicron-BA1,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Omicron-BA1,,7.8[Xiaojian Han et al.£» 2020],9.72(wild type)£» 19.3(B. 1. 351)[Tingting Li et al.£» 2021],,,,,,0.233;8.97(omicron)[Hangtian Guo et al.£» 2022],,<0.001;2.28(omicron)[Hangtian Guo et al.£» 2022],,,,,,,,,,,,,,,0.0111(SARS-CoV-2 qRT-PCR)£»0.0013(SARS-CoV-2 PRNT)£»0.0022(B.1.351 PRNT)[Tingting Li et al.£» 2021] && 0.01113[Xiaojian Han et al.£» 2020],,,,0.0171;0.02326(Delta)[Hangtian Guo et al.£» 2022] && 0.0031(SARS-CoV-2)£»0.0031(B.1.1.7)£»0.0062(B.1.351)[Tingting Li et al.£» 2021],,,,,CN111925444A (https://patents.google.com/patent/CN111925444A/en?oq=CN111925444A) && Hangtian Guo et al.£» 2022 (https://www.sciencedirect.com/science/article/pii/S2211124722005344) && Tingting Li et al.£» 2021 (https://www.nature.com/articles/s41467-021-26539-7) && Xiaojian Han et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.08.19.253369v2.full.pdf+html),,CQTS147 from patent. Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSDSIDYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDRGYEILTPASFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWFQHKPGKAPKLLIYGASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPYTFGQGTKLEIK,IGHV3-9 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ2 (Human),AKDRGYEILTPASFDY,QQSYSTPPYT,Expected (7WS0 and 7WS1 and 7WS2 and 7WS3 and 7WS4 and 7WS5 and 7WS6 and 7WS7)
4A8,,Ab,S; NTD,,SARS-CoV2_WT,,SARS-CoV2_WT,SARS-CoV2_Omicron-BA1,1[CN112076316A],,,,,,,,92.7[Xiangyang Chi et al.£» 2020],0.996[Xiangyang Chi et al.£» 2020],,,,,,,,,0.61[Xiangyang Chi et al.£» 2020],,,,,,0.57[CN112076316A] && 0.39[Xiangyang Chi et al.£» 2020],,,,0.58[CN112076316A],,,,,CN112076316A (https://patents.google.com/patent/CN112076316A/en) && Dhiraj Mannar et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.19.473380v1) && Xiangyang Chi et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/19/science.abc6952/tab-pdf),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETMYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATSTAVAGTPDLFDYYYGMDVWGQGTTVTVSS,EIVMTQSPLSSPVTLGQPASISCRSSQSLVHSDGNTYLSWLQQRPGQPPRLLIYKISNRFSGVPDRFSGSGAGTDFTLKISRVEAEDVGVYYCTQATQFPYTFGQGTKVDIK,IGHV1-24 (Human),IGHJ6 (Human),IGKV2-24 (Human),IGKJ3 (Human),ATSTAVAGTPDLFDYYYGMDV,TQATQFPYT,http://www.rcsb.org/structure/7C2L
4B7,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,0.3866[CN111732655A] && 0.3866[CN112076316A],0.217[CN111732655A] && 0.217[CN112076316A],,,0.4533[CN111732655A] && 0.4533[CN112076316A],,,,,,,,,,,,,,0.001808[CN112076316A],,0.002156[CN112076316A],,,,0.38[CN111732655A] && 0.96[CN112076316A],,,,0.052[CN111732655A] && 0.052[CN112076316A],,,,,CN111732655A (https://patents.google.com/patent/CN111732655A/en) && CN112076316A (https://patents.google.com/patent/CN112076316A/en),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFPFSSYAMSWVRQAPGKGLEWVSAITGSGGSTYYADSVKGRFTISRDNSKNTLYLHMNSLRAEDTAVYYCAKDDYGDYVLGAFDIWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGTYKFVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTLVFGGGTKLTVL,IGHV3-23 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ3 (Human),AKDDYGDYVLGAFDI,CSYAGSSTLV,ND
DK12,,Ab,S; RBD,,SARS-CoV2_WT,,,SARS-CoV2_WT,18.56[CN111978395A] && 5.6[Lina Jia et al.£» 2021],,,,,,,,,,,,,,,,,,0.107nM[Lina Jia et al.£» 2021],,,,,,,,,,n.d.[CN111978395A] && 0.34nM[Lina Jia et al.£» 2021],2.69nM[Lina Jia et al.£» 2021],,,,CN111978395A (https://patents.google.com/patent/CN111978395A/en) && Lina Jia et al.£» 2021 (https://onlinelibrary.wiley.com/doi/full/10.1002/mco2.79),,Also known as MA5 in paper. Complete,Immunised Mouse,EVMLVESGGGLVKPGGSLKLSCAASGFMFSRYAMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRFTMSRDNAKNTLYLQMSSLRSEDTAMYNCARHDGNYVDYAMDYWGQGTSVTVSS,QIVLTQSPAIMSASLGEEITLTCSASSSVSHMHWYQQKSGTSPKLLIYSTFNLASGVPSRFSGSGSGTFYSLTISSVEAEDAADYYCHQWSSWTFGGGTKLEIK,IGHV5-9-1 (Mouse),IGHJ4 (Mouse),IGKV4-80 (Mouse),IGKJ1 (Mouse),ARHDGNYVDYAMDY,HQWSSWT,ND
CC12.1,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Delta,SARS-CoV1;SARS-CoV2_Beta;SARS-CoV2_Gamma,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Delta,SARS-CoV1;SARS-CoV2_Beta;SARS-CoV2_Gamma,0.349;NA(Mu);3.47(C.1.2)£»5.58(Omicron)[Bin Ju et al.£» 2022] && 2.49[Rui Shi et al.£» 2020] && 15.1;N.D.(K417N);N.D.(K417T);16.1(L452R);27.2(E484K);16.4(E484Q);85.3(Alpha);N.D.(Beta);N.D.(Gamma);14.4(Kappa)[Fangzhu Zhao et al.£» 2023],,,,,,,17[Meng Yuan et al.£» 2020],,,,,,0.042[Thomas Rogers et al.£» 2020],,0.017[Thomas Rogers et al.£» 2020],,,,,,,,,0.022[Thomas Rogers et al.£» 2020],,,,0.009;>50(Beta);0.612(Delta);0.101(Mu);0.053(C.1.2);>50(Omicron);[Bin Ju et al.£» 2022] && 0.036(SARS-COV-2)£»0.140(Alpha)£»>20(Beta)£»>20(Gamma)£»0.025(Kappa)£»0.034(Delta)£»>20(Delta Plus)[Nitin Hingankar et al.£» 2021] && 0.019[Thomas Rogers et al.£» 2020],,,,,Bin Ju et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.01.19.476892v1) && Meng Yuan et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.06.08.141267v1) && Nitin Hingankar et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.25.474152v1) && Thomas Rogers et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc7520),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDVYGLDVWGQGTTVTVSS,DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPKFTFGPGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-9 (Human),IGKJ3 (Human),ARDLDVYGLDV,QQLNSYPPKFT,https://www.rcsb.org/structure/6XC2; https://www.rcsb.org/structure/6XC3
MnC4t2p1_E6,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,40,,,,,,,,,,,,,,,,,,,,0.03,,,,50,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGHLVQPGRSLRLSCAASGFTFDDYAMHWVRQVPGKGLEWVSGISWNGGILGYADSVKGRFTISRDNAKNSLYLQMRSLRTDDTALYYCAKDLRRQDYYADWYFDLWGRGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASTLLSAVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGNSFPFTFGPGTKVDV,IGHV3-9 (Human),IGHJ2 (Human),IGKV1-12 (Human),IGKJ3 (Human),AKDLRRQDYYADWYFDL,QQGNSFPFT,ND
CV07-283,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,,0.0475,,,,,,,,,,,,,,,,,,0.004,,,,,,0.0169,,,,,,,,,Jakob Kreye et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.08.15.252320v1.full.pdf),Jakob Kreye et al.£» 2020 (https://www.cell.com/cell/fulltext/S0092-8674(20)31246-0),Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGASAKVSCKASGYTFTGYYIHWVRQAPGQGLEWMGLINPISGGTNYAQKFQDRVTMTRDTSISTAYMELSRLRSDDTAVYYCVRGPFYYDSSGPLGGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSGDVGGYNYVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTYVFGTGTKVTVLGQPKANPTVTL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ1 (Human),VRGPFYYDSSGPLGGMDV,SSYTSSSTYV,ND
DK7,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,1.24[CN111978395A] && 0.67[Lina Jia et al.£» 2021],,,,,,,,,,,,,,,,,,0.095nM[Lina Jia et al.£» 2021],,,,,,0.198nM[Lina Jia et al.£» 2021],,,,0.071[CN111978395A] && 0.47nM[Lina Jia et al.£» 2021],0.35nM[Lina Jia et al.£» 2021],,,,CN111978395A (https://patents.google.com/patent/CN111978395A/en) && Lina Jia et al.£» 2021 (https://onlinelibrary.wiley.com/doi/full/10.1002/mco2.79),,Complete,Immunised Mouse,QVQLQQPGAELVKPGASVKMSCKASGYTFTSYSMHWVKQTPGQGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARDYHYDGYYVILDYWGQGTTLTVSS,DIQMTQSPSSLSASLGERVSLTCRASQEISGYLSWLQQKPDGTIKRLIYAASTLDSGVPKRFSGSRSGSDYSLTISSLESEDFADYYCLQYASYPWTFGGGTKLEIK,IGHV1-12 (Mouse),IGHJ2 (Mouse),IGKV9-124 (Mouse),IGKJ1 (Mouse),ARDYHYDGYYVILDY,LQYASYPWT,ND
S2-E12,,Ab,S; RBD,¢ña£»1,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1,,66(pH7.4)£» 60(pH5.4)[M. Alejandra Tortorici et al.£» 2020],,,,68(pH7.4)£» 42(pH5.4)[M. Alejandra Tortorici et al.£» 2020],,,1.7[Tyler Starr et al.£» 2021],,1.7[Tyler Starr et al.£» 2021],,,,,,,,,,,,,,,0.0042[M. Alejandra Tortorici et al.£» 2020] && 0.004[Tyler Starr et al.£» 2021],0.0793[M. Alejandra Tortorici et al.£» 2020],,0.0037;0.896(Omicron)[Elisabetta Cameroni et al.£» 2021],0.0023(SARS-COV2-2 VSV)£»0.0093(SARS-COV-2 MLV)[M. Alejandra Tortorici et al.£» 2020] && 0.0014(D614G)£»0.0068(B.1.1.7)£»0.0022(B.1.361)£»<0.0006(P.1)£»0.0011(B.1.617.2)£»0.0381(B.1.1.529)[Tongqing Zhou et al.£» 2021] && 0.002(VSV pp)[Tyler Starr et al.£» 2021],0.0029(D614G)£»0.0033(B.1.1.7)£»0.0041(B.1.361)£»0.0025(P.1)£»0.0024(B.1.617.2)£»0.112(B.1.1.529)[Tongqing Zhou et al.£» 2021],,,,Elisabetta Cameroni et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.12.472269v1) && M. Alejandra Tortorici et al.£» 2020 (https://science.sciencemag.org/content/early/2020/09/23/science.abe3354) && Tongqing Zhou et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.27.474307v1) && Tyler Starr et al.£» 2021 (https://www.nature.com/articles/s41586-021-03807-6),Elisabetta Cameroni et al.£» 2021 (https://www.nature.com/articles/s41586-021-04386-2),Variant binding data in Starr et al. Debate as to strength of Omicron-BA1 neutralisation. Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGPEVKKPGTSVRVSCKASGFTFTSSAVQWVRQARGQRLEWVGWIVVGSGNTNYAQKFHERVTITRDMSTSTAYMELSSLRSEDTAVYYCASPYCSGGSCSDGFDIWGQGTMVTVSS,DIVLTQTPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVGLTGWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),ASPYCSGGSCSDGFDI,QQYVGLTGWT,https://www.rcsb.org/structure/7K4N;https://www.rcsb.org/structure/7K45;https://www.rcsb.org/structure/7K3Q;https://www.rcsb.org/structure/7R6X
REGN10989,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,3.65;0.00923(Fc)[Johanna Hansen et al.£» 2020],,,0.0412[Johanna Hansen et al.£» 2020],,,,,,,,,,0.0433nm[Johanna Hansen et al.£» 2020],,,,,,,,,,,0.00738nm[Johanna Hansen et al.£» 2020],,,,0.00078;0.000059(Alpha);0.00794(N501Y);0.0001(D405A);0.00261(A435G);3.222(G446V);0.00147(A475V);0.3817(T478I);6.06(F486A);>50(E309D);>50(F342L);>50(A372T);>50(T376A);>50(R491A);>50(K386A);>50(IS69V);>50(SARS);>50(WIV-1)[CN113173995A] && 0.00723nm[Johanna Hansen et al.£» 2020],,,,,CN113173995A (https://patents.google.com/patent/CN113173995A/en) && Johanna Hansen et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abd0827) && Richard Copin et al.£» 2021 (https://www.sciencedirect.com/science/article/pii/S0092867421007030),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIFTGYYMHWVRQAPGQGLEWMGWINPNSGGANYAQKFQGRVTLTRDTSITTVYMELSRLRFDDTAVYYCARGSRYDWNQNNWFDPWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGTYNYVSWYQQHPGKAPKLMIFDVSNRPSGVSDRFSGSKSGNTASLTISGLQAEDEADYYCSSFTTSSTVVFGGGTKLTVL,IGHV1-2 (Human),IGHJ5 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGSRYDWNQNNWFDP,SSFTTSSTVV,https://www.rcsb.org/structure/7M42
FnC1t2p1_D4,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,0.1,,,,,,,,,,,,,,,,,,,,0.02,,,,0.28,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFLRFAMNWLRQAPGQGLEWMGWIDTNTGTPTYAQGFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARSLRGANLVPWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDVSNYLNWYQQQPGKAPKLLIYDAFNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV7-4-1 (Human),IGHJ5 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARSLRGANLVP,QQYDNLPLT,ND
HbnC3t1p2_C6,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,16,,,,,,,,,,,,,,,,,,,,0.04,,,,0.33,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,QMQLVQSGPEVKKPGTSVKVSCKASGFTFSSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQGRVTITRDMSTRTAYMELSSLRSEDTAMYYCAAPYCSSTRCYDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGRSPWTFGQGTKVEI,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSSTRCYDAFDI,QQYGRSPWT,ND
CC12.11,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,SARS-CoV1,255,,,,,,,,,,,,,1.2,,0.36,,,,,,,,,0.16,,,,0.14,,,,,Thomas Rogers et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc7520),,Complete. SHM % listed in paper.,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYIFSGYYTHWVRQAPGQGLEWMGWISPDSGGTNYAQKFQGRVTMTRDTSITTAYVELSGLRSDDTAVYYCARGPRYSGTYFDYWGQGTLVTVSS,QSVLTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKVPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSAQLFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARGPRYSGTYFDY,SSYTSSSAQL,ND
MnC4t2p1_B3,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,0.09,,,,,,,,,,,,,,,,,,,,0.06,,,,0.66,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGHLVQPGRSLRLSCAASGFTFDDYAMHWVRQVPGKGLEWVSGISWNGGILDYADSVKGRFTISRDNAKNSLYLHMRSLRTDDTALYYCAKDLRRQDYYADWYFDLWGRGTLVTVSS,DIQMIQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASTLLSAVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGNSFPFTFGPGTIVDV,IGHV3-9 (Human),IGHJ2 (Human),IGKV1-12 (Human),IGKJ3 (Human),AKDLRRQDYYADWYFDL,QQGNSFPFT,ND
CV38-183,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,,0.0593,,,,,,,,,,,,,,,,,,0.0054,,,,,,0.0037,,,,,,,,,Jakob Kreye et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.08.15.252320v1.full.pdf),Jakob Kreye et al.£» 2020 (https://www.cell.com/cell/fulltext/S0092-8674(20)31246-0),Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGDGWDNYYYGMDVWGQGTTVTVSS,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQHLPGTAPKLLIYANSNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGSVFGGGTKLTVLGQPKAAPSVTL,IGHV3-53 (Human),IGHJ6 (Human),IGLV1-40 (Human),IGLJ3 (Human),ARGDGWDNYYYGMDV,QSYDSSLSGSV,ND
CC6.29,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,1.2,,,,,,,,,,,,,0.015,,0.031,,,,,,,,,0.0071,,,,0.002,,,,,Thomas Rogers et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc7520),,Complete. SHM % listed in paper.,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGSELKKPGASVKVSCKASGYTFATYALNWVRQAPGQGLEWMGWVNTNTGSPTYAQGFTGRFVFSFDTSVSTAYLQIRTLKAEDTAVYYCAVYYYDSGSPGWFDPWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQTASSYLNWYQQKPGKAPNLLIYAASSLQSGVPSRFSGSGSVTDFTLTISSLQPEDFATYYCQQSYSTPPTFGQGTKVDIK,IGHV7-4-1 (Human),IGHJ5 (Human),IGKV1-39 (Human),IGKJ3 (Human),AVYYYDSGSPGWFDP,QQSYSTPPT,ND
STE73-2E9,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,2,,,,0.925,,,,,,,,,,,,,,0.2nM(scFv-Fc);0.2nM(lgG),0.2nM(scFv-Fc);0.2nM(lgG),0.2nM(scFv-Fc);0.2nM(lgG),,3.4nm,20nm,nm,,,,,,,,,Federico Bertoglio et al.£» 2021 (https://www.nature.com/articles/s41467-021-21609-2),,Complete,Phage Display (Ab£» human£» immune - SARS-CoV2),QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGWISAYNGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGKFDYWGQGTLVTVSS,QSVLTQPPSVSEAPSQRVTISCSGSSSNIGNNAVNWYQQLPGKAPKLLIYYDDVLPSGVSDRFSGSKSGTSASLAISGLQSGDEADYYCAAWDDSLSGVVFGGGTKLTVL,IGHV1-18 (Human),IGHJ4 (Human),IGLV1-36 (Human),IGLJ3 (Human),ARGKFDY,NSRDSTNDPVL,ND
Casirivimab,REGN10933,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta (weak);SARS-CoV2_Gamma (weak);SARS-CoV2_Delta,SARS-CoV2_Omicron-BA1;SARS-CoV2_Omicron-BA2,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta (weak);SARS-CoV2_Gamma (weak);SARS-CoV2_Delta,SARS-CoV2_Gamma;SARS-CoV2_Omicron-BA1;SARS-CoV2_Omicron-BA2;SARS-CoV1,0.0585;1.23(Mu);1.47(C.1.2)£»NA(Omicron)[Bin Ju et al.£» 2022] && 3.37;0.014(Fc)[Johanna Hansen et al.£» 2020],,,0.0417[Johanna Hansen et al.£» 2020],,,,,,,,,,0.0693nm[Johanna Hansen et al.£» 2020],,,,,,,,,,,n.n.(Omicron)[Franck Touret et al.£» 2022] && 0.033(SARS-CoV-2-nLuc);>10(SARS);>10(WIV-1-nLuc);>10(SHC014-nLuc)[Garrett Rappazzo et al.£» 2021] && <0.046;>100(omicron)[Hang Ma et al.£» 2022] && 0.0374nm[Johanna Hansen et al.£» 2020] && 0.011(D614G);>10(B.1.1.529)[Laura VanBlargan et al.£» 2021],,,,0.002;1.492(Beta);0.002(Delta);0.081(Mu);0.025(C.1.2);>50(Omicron);[Bin Ju et al.£» 2022] && 0.009;>10(Omicron)[Daniel Sheward et al.£» 2021] && 0.0076(D614G);0.03(S371F);0.0138(T376A);0.1087(D405N);0.0444(R408S);0.0138(Delta);n.n.(BA.1);n.n.(BA.2)[Hao Zhou et al.£» 2022] && 0.0428nm[Johanna Hansen et al.£» 2020] && 0.027(SARS-COV-2)£»0.004(Alpha)£»2.357(Beta)£»>20(Gamma)£»0.061(Kappa)£»0.003(Delta)£»0.014(Delta Plus)[Nitin Hingankar et al.£» 2021] && 0.0021(D614G)£»0.0014(Alpha)£»0.0788(Beta)£»0.0079(Theta)£»>5(Omicron)[Takuya Tada et al.£» 2021] && 0.0061(D614G)£»0.0097(B.1.1.7)£»>10.0(B.1.361)£»1.5363(P.1)£»0.003(B.1.617.2)£»>10.0(B.1.1.529)[Tongqing Zhou et al.£» 2021],0.016(D614G)£»0.0291(B.1.1.7)£»>10.0(B.1.361)£»>10.0(P.1)£»0.0038(B.1.617.2)£»>10.0(B.1.1.529)[Tongqing Zhou et al.£» 2021],,,+1.6(Alpha);4.5(Lota);+2.5(Eplison);+1.2(Delta);121(Gamma);78(Beta);>1000(Omicron);>1000(Omicron+R346K);+1.1(A67V);1.8(Del69-70);1.5(T95I);1.6(G142D);+1.3(Del143-145);1.5(Del211);1.4(L212I);2.8(Ins214EPE);2.2(G339D);1.5(R346K);10(S371L);1.9(S373P);+2.1(S375F);6.4(K417N);1.7(N440K);1.6(G446S);2.4(S477N);+1.3(T478K);4.8(E484K);42(Q493R);1.0(G496S);1.5(Q498R);1.4(N501Y);+1.1(Y505H);1.7(T547K);3.1(H655Y);1.1(N679K);2.4(P691H);1.4(N764K);1.5(D769Y);2.2(N856K);+1.2(Q954H);1.3(N969K);+2.4(L981F)[Lihong Liu et al.£» 2021],Bin Ju et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.01.19.476892v1) && Celine Boschi (https://www.biorxiv.org/content/10.1101/2022.01.03.474769v1) && Daniel Sheward et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.19.473354v1) && Delphine Planas et al.£» 2021 (https://www.nature.com/articles/d41586-021-03827-2) && Delphine Planas et al.£» 2021 (https://www.nature.com/articles/s41586-021-03777-9) && Franck Touret et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.01.01.474639v1) && Garrett Rappazzo et al.£» 2021 (https://www.science.org/doi/10.1126/science.abf4830) && Hang Ma et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.02.25.482049v1) && Hao Zhou et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.02.15.480166v2) && Hirofumi Ohashi et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.02.27.482147v1) && Johanna Hansen et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abd0827) && Laura VanBlargan et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.15.472828v1) && Lihong Liu et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.14.472719v3) && Matthew McCallum et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.28.474380v1) && Nitin Hingankar et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.25.474152v1) && Sebastian Fiedler et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.02.03.478946v2) && Sho Iketani et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.02.07.479306v1) && Takuya Tada et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.28.474369v1) && Tongqing Zhou et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.27.474307v1) && Xun Wang et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.24.474138v1),,Therapeutic mAb Casirivimab/Nepuvibart. Debate as to neutralisation strength versus Beta and Gamma variants. Also may very weakly neutralise omicron variants (see Ohashi et al). Complete,B-cells; Transgenic Mouse (VelocImmune),QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYITYSGSTIYYADSVKGRFTISRDNAKSSLYLQMNSLRAEDTAVYYCARDRGTTMVPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDITNYLNWYQQKPGKAPKLLIYAASNLETGVPSRFSGSGSGTDFTFTISGLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,IGHV3-11 (Human),IGHJ4 (Human),IGKV1-33 (Human),IGKJ4 (Human),ARDRGTTMVPFDY,QQYDNLPLT,https://www.rcsb.org/structure/6XDG
S309,,Ab,S; RBD,¢ô£»3,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1;SARS-CoV2_Omicron-BA2;SARS-CoV1,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta;SARS-CoV2_Omicron-BA1;SARS-CoV2_Omicron-BA2;SARS-CoV1,,<0.02;<0.03(Mu);<0.02(C.1.2)£»2.13(Omicron)[Bin Ju et al.£» 2022] && 1.5[Luca Piccoli et al.£» 2020],,,,1.6[Luca Piccoli et al.£» 2020],,,<0.001;<0.001(SARS)[Dora Pinto et al.£» 2020] && 0.2[Tyler Starr et al.£» 2021],,<0.015(lgG);2.6(Fab)[Dora Pinto et al.£» 2020] && 0.2[Tyler Starr et al.£» 2021],,,,,,,,,,,,,,,0.079[Dora Pinto et al.£» 2020] && 0.11(SARS-CoV-2-nLuc);0.24(SARS);0.11(WIV-1-nLuc);0.15(SHC014-nLuc)[Garrett Rappazzo et al.£» 2021] && 0.202(D614G);0.373(B.1.1.529)[Laura VanBlargan et al.£» 2021] && 0.079[Tyler Starr et al.£» 2021] && 0.079[Wanwisa Dejnirattisai et al.£» 2021],,,,0.093;0.042(Beta);0.042(Delta);0.07(Mu);0.219(C.1.2);0.158(Omicron);[Bin Ju et al.£» 2022] && 0.1;0.2(Omicron)[Daniel Sheward et al.£» 2021] && 0.12-0.18[Luca Piccoli et al.£» 2020] && 0.0361(D614G)£»0.0306(B.1.1.7)£»0.0277(B.1.361)£»0.0418(P.1)£»0.0452(B.1.617.2)£»0.281(B.1.1.529)[Tongqing Zhou et al.£» 2021] && 0.031(VSV pp)[Tyler Starr et al.£» 2021],0.163(D614G)£»0.194(B.1.1.7)£»0.0974(B.1.361)£»0.359(P.1)£»0.113(B.1.617.2)£»1.336(B.1.1.529)[Tongqing Zhou et al.£» 2021],,,,Bin Ju et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.01.19.476892v1) && Daniel Sheward et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.19.473354v1) && Dhiraj Mannar et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.19.473380v1) && Dora Pinto et al.£» 2020 (https://www.nature.com/articles/s41586-020-2349-y) && Garrett Rappazzo et al.£» 2021 (https://www.science.org/doi/10.1126/science.abf4830) && Laura VanBlargan et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.15.472828v1) && Luca Piccoli et al.£» 2020 (https://www.cell.com/cell/fulltext/S0092-8674(20)31234-4) && Matthew McCallum et al.£» 2021 (https://dx.doi.org/10.1126/science.abn8652) && Sho Iketani et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.02.07.479306v1) && Tongqing Zhou et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.27.474307v1) && Tyler Starr et al.£» 2021 (https://www.nature.com/articles/s41586-021-03807-6) && Wanwisa Dejnirattisai et al.£» 2021 (https://www.cell.com/cell/fulltext/S0092-8674(21)00221-X),,Extra variant binding data in Starr et al. Complete,B-cells; SARS-CoV1 Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYPFTSYGISWVRQAPGQGLEWMGWISTYNGNTNYAQKFQGRVTMTTDTSTTTGYMELRRLRSDDTAVYYCARDYTRGAWFGESLIGGFDNWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQTVSSTSLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQHDTSLTFGGGTKVEIK,IGHV1-18 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ4 (Human),ARDYTRGAWFGESLIGGFDN,QQHDTSLT,https://www.rcsb.org/structure/6WPS;https://www.rcsb.org/structure/6WPT;https://www.rcsb.org/structure/6WS6;https://www.rcsb.org/structure/7JX3;https://www.rcsb.org/structure/7L0N; https://www.rcsb.org/structure/7BEP;https://www.rcsb.org/structure/7R6W;https://www.rcsb.org/structure/7R6X;https://www.rcsb.org/structure/7SOB;https://www.rcsb.org/structure/7TLY;https://www.rcsb.org/structure/7TLZ;https://www.rcsb.org/structure/7TM0;https://www.rcsb.org/structure/7TN0
CnC2t1p1_E12,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,38,,,,,,,,,,,,,,,,,,,,0.03,,,,3.13,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLVQPGRSLRLSCTASGFTFGDYAMSWFRQAPGKGLEWVGFIRSKAYGGTTEYAASVKGRFTISRDDSKSIVYLQMNSLKTEDTAVYYCTRVRRLWFGSYYYGMDVWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPGTFGPGTKVDIK,IGHV3-49 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ3 (Human),TRVRRLWFGSYYYGMDV,MQALQTPGT,ND
CV07-222,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,,0.00697,,,,,,,,,,,,,,,,,,0.0055,,,,,,0.0078,,,,,,,,,Jakob Kreye et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.08.15.252320v1.full.pdf),Jakob Kreye et al.£» 2020 (https://www.cell.com/cell/fulltext/S0092-8674(20)31246-0),Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYVHWVRQAPGQGLEWMGWINPISGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGPYYYDSSGSLGAFDIWGQGTMVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEAHYYCCSYAGGSTSYVFGTGTKVTVL,IGHV1-2 (Human),IGHJ3 (Human),IGLV2-23 (Human),IGLJ1 (Human),ARGPYYYDSSGSLGAFDI,CSYAGGSTSYV,ND
CV-X1-126,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,,0.243,,,,,,,,,,,,,,,,,,0.0055,,,,,,0.0716,,,,,,,,,Jakob Kreye et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.08.15.252320v1.full.pdf),Jakob Kreye et al.£» 2020 (https://www.cell.com/cell/fulltext/S0092-8674(20)31246-0),Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRHNSKNTLYLQMNSVRAEDTAVYYCARDLSEGGMDVWGQGTTVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANGFPPLFGGGTKVEIK,IGHV3-53 (Human),IGHJ6 (Human),IGKV1-12 (Human),IGKJ4 (Human),ARDLSEGGMDV,QQANGFPPL,ND
CV07-315,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,,0.0112,,,,,,,,,,,,,,,,,,0.0072,,,,,,0.0249,,,,,,,,,Jakob Kreye et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.08.15.252320v1.full.pdf),Jakob Kreye et al.£» 2020 (https://www.cell.com/cell/fulltext/S0092-8674(20)31246-0),Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGISWNSGSIGYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTALYYCAKDFLWDLHPPRYYGMDVWGQGTTVTVSS,QSVLTRPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYENNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLNGVFGGGTKLTVLGQPKAAPSVTL,IGHV3-9 (Human),IGHJ6 (Human),IGLV1-51 (Human),IGLJ3 (Human),AKDFLWDLHPPRYYGMDV,QQSYSTHA,ND
CC12.17,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT (weak),SARS-CoV1,175,,,,,,,,,,,,,0.044,,0.02,,,,,,,,,8.6,,,,2.1,,,,,Thomas Rogers et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc7520),,Complete. SHM % listed in paper.,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGVVQPGRSLRLSCAASGFTFRNYGMHWVRQAPGKGLEGVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSSGSYYYYYYGMDVWGQGTTVTVSS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDTDRPSGIPERFSGSSSGNTATLTISRVEAGDEADYYCQVWDSSSDHPVVFGGGTKLTVL,IGHV3-30 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKSSGSYYYYYYGMDV,QVWDSSSDHPVV,ND
CR3022,,Ab,S; RBD,,SARS-CoV1;SARS-CoV2_WT,,SARS-CoV1,SARS-CoV2_WT,0.349;NA(Mu);3.47(C.1.2)£»5.58(Omicron)[Bin Ju et al.£» 2022] && 2.49[Rui Shi et al.£» 2020] && 15.1;N.D.(K417N);N.D.(K417T);16.1(L452R);27.2(E484K);16.4(E484Q);85.3(Alpha);N.D.(Beta);N.D.(Gamma);14.4(Kappa)[Fangzhu Zhao et al.£» 2028],,,,,,,115(SARS-COV-2)£» 1(SARS-COV)[Meng Yuan et al.£» 2020a],,,,,,,,,,,,,,,,,,,,,11(SARS)[Jan ter Meulen et al.£» 2006],,,23.5(SARS)[Jan ter Meulen et al.£» 2006],,Charlie Nichols et al.£» 2020 (https://www.frontiersin.org/articles/10.3389/fphar.2020.615211/full) && Fangzhu Zhao et al.£» 2022 (https://www.biorxiv.org/content/10.1101/2022.01.06.475303v1.full.pdf) && Jan ter Meulen et al.£» 2006 (https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0030237) && Meng Yuan et al.£» 2020a (https://science.sciencemag.org/content/early/2020/04/02/science.abb7269) && Meng Yuan et al.£» 2020b (https://www.biorxiv.org/content/10.1101/2020.06.08.141267v1) && Nicholas Wu et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.09.21.305441v1),,Complete,B-cells; SARS-CoV1 Human Patient,QMQLVQSGTEVKKPGESLKISCKGSGYGFITYWIGWVRQMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGSGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLYSSINKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKVEIK,IGHV5-51 (Human),IGHJ6 (Human),IGKV4-1 (Human),IGKJ1 (Human),AGGSGISTPMDV,QQYYSTPYT,https://www.rcsb.org/structure/6W41; https://www.rcsb.org/structure/6W7Y; https://www.rcsb.org/structure/6YLA; https://www.rcsb.org/structure/6YM0; https://www.rcsb.org/structure/6XC3; https://www.rcsb.org/structure/6XC7; https://www.rcsb.org/structure/6ZH9; https://www.rcsb.org/structure/6ZLR; https://www.rcsb.org/structure/7A5R; https://www.rcsb.org/structure/7A5S; https://www.rcsb.org/structure/7JN5; https://www.rcsb.org/structure/7LOP; https://www.rcsb.org/structure/7M6D; https://www.rcsb.org/structure/7R8L
CV07-287,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,,0.16,,,,,,,,,,,,,,,,,,0.0059,,,,,,0.0417,,,,,,,,,Jakob Kreye et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.08.15.252320v1.full.pdf),Jakob Kreye et al.£» 2020 (https://www.cell.com/cell/fulltext/S0092-8674(20)31246-0),Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAMQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSTNCYDAFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPYCSSTNCYDAFDI,QQYGSSPWT,Expected (7S5R)
HbnC3t1p1_G4,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,1.5,,,,,,,,,,,,,,,,,,,,0.02,,,,0.12,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDFGDFFFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGVSSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK,IGHV3-66 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDFGDFFFDY,QQYGSSPRT,ND
C121,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,SARS-CoV1,0.5;0.8(R346K);0.8(N439K);0.6(N440K);0.7(A475V);0.8(V483A);n.b.(E484K);111(Q493R)[Christopher Barnes et al.£» 2020] && 2.4[Raoul De Gasparo et al.£» 2021],,,,0.13[Raoul De Gasparo et al.£» 2021],,,,,,,,,,,,,,0.0028464999999999996[Davide Robbiani et al.£» 2020],,,,,,0.0067[Christopher Barnes et al.£» 2020] && 0.00164[Davide Robbiani et al.£» 2020],,0.0223[Christopher Barnes et al.£» 2020],,0.00672975713439852[Davide Robbiani et al.£» 2020],0.01431404411259715[Davide Robbiani et al.£» 2020],0.0223319377564905[Davide Robbiani et al.£» 2020],,,Christopher Barnes et al.£» 2020 (https://www.nature.com/articles/s41586-020-2852-1) && Davide Robbiani et al.£» 2020 (https://www.nature.com/articles/s41586-020-2456-9) && Raoul De Gasparo et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.01.22.427567v1),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWISPVSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARAPLFPTGVLAGDYYYYGMDVWGQGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEGSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTLVFGGGTKLTVL,IGHV1-2 (Human),IGHJ6 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARAPLFPTGVLAGDYYYYGMDV,CSYAGSSTLV,https://www.rcsb.org/structure/7K8X; https://www.rcsb.org/structure/7K8Y; https://www.rcsb.org/structure/7K8Q
DK17,,Ab,S; RBD,,SARS-CoV2_WT,,,SARS-CoV2_WT,4[CN111978395A] && 36.5[Lina Jia et al.£» 2021],,,,,,,,,,,,,,,,,,0.29nM[Lina Jia et al.£» 2021],,,,,,,,,,n.d.[CN111978395A],,,,,CN111978395A (https://patents.google.com/patent/CN111978395A/en) && Lina Jia et al.£» 2021 (https://onlinelibrary.wiley.com/doi/full/10.1002/mco2.79),,Either MA12 or MA15 in paper. Complete,Immunised Mouse,QVQLQQPGAELVRPGASVKLSCKASGYTFISYWIHWVKQRPGQGLEWIGEIDPSDSYSNYNQNFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYYCARSELWAMDYWGQGTSVTVSS,DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSHGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPWTFGGGTKLEI,IGHV1-69 (Mouse),IGHJ4 (Mouse),IGKV2-109 (Mouse),IGKJ1 (Mouse),ARSELWAMDY,AQNLELPWT,ND
MnC4t2p1_D10,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,440,,,,,,,,,,,,,,,,,,,,0.18,,,,21.02,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,QLQVQESGPGLVKPSETLSLTCTVSGASISSNHYFWGWIRQPPGKGLAWIGSMHYSGSTYYNPSLKSRVTISVDTSKNQLSLKLSSVTAADTAVYYCARGVNYYDRNGYYRNDGFDIRGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYEQKPGKAPKRLIYAASSLESGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNTYPFTFGPGTRVDIK,IGHV4-39 (Human),IGHJ3 (Human),IGKV1-17 (Human),IGKJ3 (Human),ARGVNYYDRNGYYRNDGFDI,LQHNTYPFT,ND
HbnC3t1p1_C6,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,0.19[Christoph Kreer et al.£» 2020],,,,,,,,,,,,,,,,,,,,0.06[Christoph Kreer et al.£» 2020],,,,0.04[Christoph Kreer et al.£» 2020],,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044) && PDB (https://www.rcsb.org/structure/7B0B),,Complete,B-cells; SARS-CoV2_WT Human Patient,QMQLVQSGPEVKKPGTSVKVSCKASGFTFTSSAVQWVRQARGQRLEWIGWIVVGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPHCSSTICYDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRVEPEDFAVYYCQQYGSSPWTFGQGTKVEIK,IGHV1-58 (Human),IGHJ3 (Human),IGKV3-20 (Human),IGKJ1 (Human),AAPHCSSTICYDGFDI,QQYGSSPWT,https://www.rcsb.org/structure/7B0B
CC12.19,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT (weak),SARS-CoV1,26,,,,,,,,,,,,,0.019,,0.012,,,,,,,,,43,,,,,,,,,Thomas Rogers et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc7520),,Complete. SHM % listed in paper.,B-cells; SARS-CoV2_WT Human Patient,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGSGSGSYPNYYYYYGMDVWGQGTTVTVSS,SYELTQSPSVSVAPGQTARITCGGNNIGSKSVHWYQRKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDNNSDHLVFGGGTKLTVL,IGHV3-23 (Human),IGHJ6 (Human),IGLV3-21 (Human),IGLJ3 (Human),AKGSGSGSYPNYYYYYGMDV,QVWDNNSDHLV,ND
Regdanivimab,CT-P59,Ab,S; RBD,,,,,,0.027[Cheolmin Kim et al.£» 2021],,,,,,,0.251;0.282(A435S);0.198(F342L);0.161(G476S);0.236(K458R);0.294(N354D);0.292(V367F);0.391(V483A);0.221(W436R)[Cheolmin Kim et al.£» 2021],,,,,,,,,,,,,,,,,,,,,0.0084[Cheolmin Kim et al.£» 2021] && 0.002nm(D614G);0.286(Beta)[Larisa Troitskaya et al.£» 2021],,,,,Cheolmin Kim et al.£» 2021 (https://www.nature.com/articles/s41467-020-20602-5) && Larisa Troitskaya et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.07.05.451203v1),,,,QITLKESGPTLVKPTQTLTLTCSFSGFSLSTSGVGVGWIRQPPGKALEWLALIDWDDNKYHTTSLKTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARIPGFLRYRNRYYYYGMDVWGQGTTVTVSS,ELVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAGVFGGGTELTVL,IGHV2-70 (Human),IGHJ6 (Human),IGLV1-51 (Human),IGLJ3 (Human),ARIPGFLRYRNRYYYYGMDV,GTWDSSLSAGV,https://www.rcsb.org/structure/7CM4
DK9,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,1.11[CN111978395A] && 1.51[Lina Jia et al.£» 2021],,,,,,,,,,,,,,,,,,0.347nM[Lina Jia et al.£» 2021],,,,,,0.093nM[Lina Jia et al.£» 2021],,,,0.017[CN111978395A],,,,,CN111978395A (https://patents.google.com/patent/CN111978395A/en) && Lina Jia et al.£» 2021 (https://onlinelibrary.wiley.com/doi/full/10.1002/mco2.79),,Also known as MA3 in paper. Complete,Immunised Mouse,EVQLQQSGPELVKPGASVKISCKTSGYTETEYTMHWVKQSHGKSLEWIGGINPNNGDTIYNQKFKGKATLTVDKSSSTAYMELRSLTSEDSAVYCCAREDYGSSYAYWGQGTLVTVSA,DIVMSQSPSSLAVSVGEKVTMSCKSSQSLLYNSNQKKYLAWYQQKPGQSPKLLTYWASTRESGVPDRFTGSGSGTDFTLTISSVKAEDLAIYYCQQYYSYPLTFGAGTKLELK,IGHV1-26 (Mouse),IGHJ3 (Mouse),IGKV8-30 (Mouse),IGKJ5 (Mouse),AREDYGSSYAY,QQYYSYPLT,ND
35B5,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Beta;SARS-CoV2_Delta,,SARS-CoV2_WT;SARS-CoV2_Beta;SARS-CoV2_Delta,,0.00219[CN113388031B] && 10.9[Xiaofei Wang et al.£» 2022],,,,,,,,,,,,,,,,,,0.0183[Xiaofei Wang et al.£» 2022] && 0.0195(WT)£»0.0207(Delta)£»0.0618(Omicron)[Xiaofei Wang et al.£» 2022],,,,,,0.0025;0.00728(D614G);0.01304(501Y .V2)[CN113388031B] && 0.0025(WT)£»0.729(D614G)£»0.01304(B.1.351)£»0.00563(B.1.617.2)[Xiaofei Wang et al.£» 2022] && 0.0499(Omicron)[Xiaofei Wang et al.£» 2022],,,,0.0024(WT)£»0.0069(Delta)£»0.0147(Omicron)[Xiaofei Wang et al.£» 2022],,,,,CN113388031B (https://patents.google.com/patent/CN113388031B/en) && Xiaofei Wang et al.£» 2022 (https://www.nature.com/articles/s41392-022-00954-8) && Xiaofei Wang et al.£» 2022 (https://www.sciencedirect.com/science/article/pii/S1931312822001652),,Complete,Transgenic Mouse,QVQLLESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSGVSWNSGTIGYADSVKGRFTISRDNAKNSLYLHMRSLRAEDTALYYCAKAVEMVRGLMGLGADPEYGMDVWGQGTTVTVSS,DIVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQALQTPFTFGPGTKVDIK,IGHV3-9 (Human),IGHJ6 (Human),IGKV2-28 (Human),IGKJ3 (Human),AKAVEMVRGLMGLGADPEYGMDV,MQALQTPFT,https://www.rcsb.org/structure/7E9P;https://www.rcsb.org/structure/7F46;https://www.rcsb.org/structure/7E9N
m336,,Ab,S; RBD,,MERS-CoV,,MERS-CoV,,4.27[Tianlei Ying et al.£» 2004],1.489[Tianlei Ying et al.£» 2015],,,,,,,,,,,,0.034[Tianlei Ying et al.£» 2004],,,,,,,,,,,0.07[Tianlei Ying et al.£» 2004] && 0.07[Tianlei Ying et al.£» 2015],,,,0.005[Tianlei Ying et al.£» 2004] && 0.005[Tianlei Ying et al.£» 2015],0.039[Tianlei Ying et al.£» 2004],,,,Tianlei Ying et al.£» 2004 (https://jvi.asm.org/content/88/14/7796) && Tianlei Ying et al.£» 2015 (https://www.nature.com/articles/ncomms9223),,Complete,B-cells; MERS-CoV Human Patient,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTASYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARVGYCSSTSCNRGAFDIWGQGTMVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK,IGHV1-69 (Human),IGHJ3 (Human),IGKV1-17 (Human),IGKJ4 (Human),ARVGYCSSTSCNRGAFDI,QQLNSYPLT,https://www.rcsb.org/structure/4XAK
CV07-250,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,,0.0564,,,,,,,,,,,,,,,,,,0.0087,,,,,,0.0035,,,,,,,,,Jakob Kreye et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.08.15.252320v1.full.pdf),Jakob Kreye et al.£» 2020 (https://www.cell.com/cell/fulltext/S0092-8674(20)31246-0),Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSEAEVKEPGASVEVSCKASGYNFTNFAISWVRQAPGQGLEWMGWISGYNGDTNSAQKFLGRVTMTTDTSTTTAYMELRSLRSDDTAVYYCAGSDNYGFPYNGMDVWGQGTTVTVFN,QSALTQPPSASGSPGQSVTISCTGTSSDLGAYHFVTWYQHYPGKAPKVMIYGVRKRPSGVPDRFSGSKSGNTASLTVSGLQDEDEADYYCSSYAGNNDFVFGGGTKLTVL,IGHV1-18 (Human),IGHJ6 (Human),IGLV2-8 (Human),IGLJ3 (Human),AGSDNYGFPYNGMDV,SSYAGNNDFV,https://www.rcsb.org/structure/6XKQ
DK6,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,0.67[CN111978395A] && 0.26[Lina Jia et al.£» 2021],,,,,,,,,,,,,,,,,,0.096nM[Lina Jia et al.£» 2021],,,,,,0.169nM[Lina Jia et al.£» 2021],,,,0.071[CN111978395A] && 0.1nM[Lina Jia et al.£» 2021],0.5nM[Lina Jia et al.£» 2021],,,,CN111978395A (https://patents.google.com/patent/CN111978395A/en) && Lina Jia et al.£» 2021 (https://onlinelibrary.wiley.com/doi/full/10.1002/mco2.79),,Complete,Immunised Mouse,QVQLQQPGTELVKPGASVKMSCKASGYTFTSYSIHWVKQTPGQGLEWIGALYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARDYHYDGYYVTILDYWGQGTTLTVSS,DIQMTQSPSSLSASLGERVSLTCRASQEISGYLSWLQQKPDGTIKRLIYAASTLDSGVPKRFSGSRSGSDYSLTISSLESEDFADYYCLQYASYPWTFGGGTKLEIK,IGHV1-12 (Mouse),IGHJ2 (Mouse),IGKV9-124 (Mouse),IGKJ1 (Mouse),ARDYHYDGYYVTILDY,LQYASYPWT,ND
MnC4t2p1_F5,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,89,,,,,,,,,,,,,,,,,,,,0.07,,,,100,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,QLQVQESGPGLVKPSETLSLTCTVSGASISSNHYFWGWIRQPPGKGLAWIGSMHYSGSTYYNPSLKSRVTISVDTSKNQLSLKLSSVTAADTAVYYCARGVNYYDRNGYYRNDGFDIRGQGTMVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYEQKPGKAPKRLIYAASSLESGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLQHNTYPFTFGPGTRVDIK,IGHV4-39 (Human),IGHJ3 (Human),IGKV1-17 (Human),IGKJ3 (Human),ARGVNYYDRNGYYRNDGFDI,LQHNTYPFT,ND
C102,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,SARS-CoV1,27;72(R346K);32(N439K);55(N440K);395(A475V);32(V483A);61(E484K);81(Q493R)[Christopher Barnes et al.£» 2020],,,,,,,,,,,,,,,,,,0.0045415[Davide Robbiani et al.£» 2020],,,,,,0.034[Christopher Barnes et al.£» 2020],,0.143[Christopher Barnes et al.£» 2020],,0.0340253003588593[Davide Robbiani et al.£» 2020],0.08421290435941595[Davide Robbiani et al.£» 2020],0.14322677108389598[Davide Robbiani et al.£» 2020],,,Christopher Barnes et al.£» 2020 (https://www.sciencedirect.com/science/article/pii/S0092867420307571) && Davide Robbiani et al.£» 2020 (https://www.nature.com/articles/s41586-020-2456-9),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYGDYYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ1 (Human),ARDYGDYYFDY,QQYGSSPRT,https://www.rcsb.org/structure/7K8M; https://www.rcsb.org/structure/7K8N
4A3,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,SARS-CoV1,3.62[Xiaoyu Liu et al.£» 2020],,,,,,,3.62[CN111592595A],,,,,,,,,,,,,,,,,0.28[CN111592595A],,,,0.28[Xiaoyu Liu et al.£» 2020],,,,,CN111592595A (https://patentimages.storage.googleapis.com/ca/4f/d6/8b54080db2f1e3/CN111592595A.pdf) && CN112062838A (https://patents.google.com/patent/CN112062838A/en) && Xiaoyu Liu et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.05.03.074914v2),,Complete,Phage Display (Ab£» human£» non-immune),EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSSIASSGYYTDYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDADSFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASYLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQAYSAPSTFGQGTKVEIK,IGHV3-23 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),AKDADSFDY,QQAYSAPST,ND
CnC2t1p1_E8,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,3.2,,,,,,,,,,,,,,,,,,,,0.13,,,,4.42,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKNPGASVKVSCKASGYIFTNYYIHWVRQAPGQGLEWVGWIHSLSGGTSYAQKFQGRVTLTRDASIRTAYMELSRLGSDDTALYYCARASVSTITDFDYWGQGTLVAVSS,QSALTQPASVSGSPGQSITISCTGTSGDVGSYNLVSWYQQHPGKAPKLVIYEATKRPSGVSNRFFASKSGNTASLTISGLQAEDEADYYCCSYAGVRTVVFGGGTKLTVL,IGHV1-2 (Human),IGHJ4 (Human),IGLV2-23 (Human),IGLJ3 (Human),ARASVSTITDFDY,CSYAGVRTVV,ND
CC12.3,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Delta;SARS-CoV2_Kappa,SARS-CoV1,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Delta;SARS-CoV2_Kappa,SARS-CoV1;SARS-CoV2_Beta,0.349;NA(Mu);3.47(C.1.2)£»5.58(Omicron)[Bin Ju et al.£» 2022] && 2.49[Rui Shi et al.£» 2020] && 15.1;N.D.(K417N);N.D.(K417T);16.1(L452R);27.2(E484K);16.4(E484Q);85.3(Alpha);N.D.(Beta);N.D.(Gamma);14.4(Kappa)[Fangzhu Zhao et al.£» 2025],,,,,,,14[Meng Yuan et al.£» 2020],,,,,,0.025[Thomas Rogers et al.£» 2020],,0.018[Thomas Rogers et al.£» 2020],,,,,,,,,0.034(SARS-COV-2)£»0.037(Alpha)£»>20(Beta)£»0.044(Kappa)£»0.013(Delta)[Nitin Hingankar et al.£» 2021] && 0.026[Thomas Rogers et al.£» 2020],,,,0.018[Thomas Rogers et al.£» 2020],,,,,Meng Yuan et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.06.08.141267v1) && Nitin Hingankar et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.25.474152v1) && Thomas Rogers et al.£» 2020 (https://science.sciencemag.org/content/early/2020/06/15/science.abc7520),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKSTLYLQMNSLRVEDTAVYYCARDFGDFYFDYWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKLEIK,IGHV3-53 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ2 (Human),ARDFGDFYFDY,QQYGSSPRT,https://www.rcsb.org/structure/6XC4; https://www.rcsb.org/structure/6XC7
DK8,,Ab,S; RBD,,SARS-CoV2_WT,,,SARS-CoV2_WT,1.51[CN111978395A] && 1.24[Lina Jia et al.£» 2021],,,,,,,,,,,,,,,,,,0.221nM[Lina Jia et al.£» 2021],,,,,,0.034nM[Lina Jia et al.£» 2021],,,,n.d.[CN111978395A] && 0.47nM[Lina Jia et al.£» 2021],0.94nM[Lina Jia et al.£» 2021],,,,CN111978395A (https://patents.google.com/patent/CN111978395A/en) && Lina Jia et al.£» 2021 (https://onlinelibrary.wiley.com/doi/full/10.1002/mco2.79),,Also known as MA16 in paper. Complete,Immunised Mouse,EVMLVESGGDLVKPGGSLKLSCAASGETESGYAMSWVRQTPEKRLEWVATISSGGSYTYYPDSVKGRETISRDNAKNILYLQMSSLRSEDTAMYYCARHDGNYVDYAMDYWGQGTSVTVSS,QLVLTQSPAIMSASLGEEITLTCSASSSVSYMHWYQQKSGTSPKLLIYTTSNLASGVPSRFSGSGSGTFYSLTISSVEAEDAADYYCHQWSCWTFGGGTKLEIK,IGHV5-9-1 (Mouse),IGHJ4 (Mouse),IGKV4-80 (Mouse),IGKJ1 (Mouse),ARHDGNYVDYAMDY,HQWSCWT,ND
CV38-142,,Ab,S; RBD,,SARS-CoV1;SARS-CoV2_WT,,SARS-CoV2_WT,,1.05[Jakob Kreye et al.£» 2020],,,,,,,29.2;53.6(SARS)[Hejun Liu et al.£» 2021],,,,,,,,,,,0.0056[Jakob Kreye et al.£» 2020],,,,,,0.0232[Jakob Kreye et al.£» 2020],,,,3.46;1.41(SARS)[Hejun Liu et al.£» 2021],,,,,Hejun Liu et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.02.11.430866v1) && Jakob Kreye et al.£» 2020 (https://www.biorxiv.org/content/10.1101/2020.08.15.252320v1.full.pdf),Hejun Liu et al.£» 2021 (https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(21)00181-5?),Complete,B-cells; SARS-CoV2_WT Human Patient,EVQLVQSGAEVKKPGESLKISCQGSGYSFTSYWIGWVRQMPGKGLEWMGIIYPGESDTRYSSSFQGHVTISADKSISTAYLQWSSLKASDTAMYYCARIRGVYSSGWIGGDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRQWTFGQGTKVEIK,IGHV5-51 (Human),IGHJ4 (Human),IGKV1-39 (Human),IGKJ1 (Human),ARIRGVYSSGWIGGDY,QQSYSTPRQWT,https://www.rcsb.org/structure/7LM8;https://www.rcsb.org/structure/7LM9
C119,,Ab,S; RBD,,SARS-CoV2_WT,SARS-CoV1,SARS-CoV2_WT,SARS-CoV1,10;22(R346K);20(N439K);21(N440K);20(A475V);22(V483A);91(E484K);20(Q493R)[Christopher Barnes et al.£» 2020],,,,,,,,,,,,,,,,,,0.003573[Davide Robbiani et al.£» 2020],,,,,,0.0091[Christopher Barnes et al.£» 2020],,0.0978[Christopher Barnes et al.£» 2020],,0.0091247249691521[Davide Robbiani et al.£» 2020],0.03945314284195495[Davide Robbiani et al.£» 2020],0.09778443918699066[Davide Robbiani et al.£» 2020],,,Christopher Barnes et al.£» 2020 (https://www.nature.com/articles/s41586-020-2852-1) && Davide Robbiani et al.£» 2020 (https://www.nature.com/articles/s41586-020-2456-9),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINPSGGSTSYAQKLQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARANHETTMDTYYYYYYMDVWGKGTTVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYKYVSWYQRHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTSVVFGGGTQLTVL,IGHV1-46 (Human),IGHJ6 (Human),IGLV2-14 (Human),IGLJ3 (Human),ARANHETTMDTYYYYYYMDV,SSYTSSSTSVV,https://www.rcsb.org/structure/7K8W
MnC4t2p2_A4,,Ab,S; RBD,,SARS-CoV2_WT,,SARS-CoV2_WT,,14,,,,,,,,,,,,,,,,,,,,0.02,,,,21.02,,,,,,,,,Christoph Kreer et al.£» 2020 (https://doi.org/10.1016/j.cell.2020.06.044),,Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVQSGSELKKPGASVKISCKASGYIFINYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQDFTGRFVFSLDTSLSTAYLQISSLEAEDTAVYYCAKIGSRNSLGVWGQGTLVTVSA,EIVLTQSPGTLSLSPGERATLSCRASHSVDRSYLAWYQQKPGLAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFALYYCQHFGTSSVTFGRGTRLEIK,IGHV7-4-1 (Human),IGHJ4 (Human),IGKV3-20 (Human),IGKJ5 (Human),AKIGSRNSLGV,QHFGTSSVT,ND
C135,,Ab,S; RBD,,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,SARS-CoV1;SARS-CoV2_Omicron-BA1,SARS-CoV2_WT;SARS-CoV2_Alpha;SARS-CoV2_Beta;SARS-CoV2_Gamma;SARS-CoV2_Delta,SARS-CoV1;SARS-CoV2_Omicron-BA1,6;n.b.(R346K);37(N439K);n.b.(N440K);12(A475V);9(V483A);7(E484K);13(Q493R)[Christopher Barnes et al.£» 2020] && 0.59[Raoul De Gasparo et al.£» 2021],,,,0.21[Raoul De Gasparo et al.£» 2021],,,,,,,,,,,,,,0.0017985[Davide Robbiani et al.£» 2020],,,,,,0.0166[Christopher Barnes et al.£» 2020] && 0.00298[Davide Robbiani et al.£» 2020],,0.0489[Christopher Barnes et al.£» 2020],,0.016611164465640003[Davide Robbiani et al.£» 2020] && 0.0108(D614G)£»0.0131(B.1.1.7)£»0.034(B.1.361)£»0.0147(P.1)£»0.0247(B.1.617.2)£»>10.0(B.1.1.529)[Tongqing Zhou et al.£» 2021],0.03281418938455395[Davide Robbiani et al.£» 2020] && 0.0643(D614G)£»0.191(B.1.1.7)£»n.d.(B.1.361)£»0.115(P.1)£»n.d.(B.1.617.2)£»>10.0(B.1.1.529)[Tongqing Zhou et al.£» 2021],0.048895035609662046[Davide Robbiani et al.£» 2020],,,Christopher Barnes et al.£» 2020 (https://www.sciencedirect.com/science/article/pii/S0092867420307571) && Davide Robbiani et al.£» 2020 (https://www.nature.com/articles/s41586-020-2456-9) && Koen Van Rompay et al.£» 2021 (https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009688) && Raoul De Gasparo et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.01.22.427567v1) && Tongqing Zhou et al.£» 2021 (https://www.biorxiv.org/content/10.1101/2021.12.27.474307v1),,Therapeutic mAb Ogalvibart. Complete,B-cells; SARS-CoV2_WT Human Patient,QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVIPFDGRNKYYADSVTGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASSSGYLFHSDYWGQGTLVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISNWLAWFQQKPGKAPKLLIYEASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYPWTFGQGTKVEIK,IGHV3-30 (Human),IGHJ4 (Human),IGKV1-5 (Human),IGKJ1 (Human),ASSSGYLFHSDY,QQYNSYPWT,https://www.rcsb.org/structure/7K8R; https://www.rcsb.org/structure/7K8Z
DK16,,Ab,S; RBD,,SARS-CoV2_WT,,,SARS-CoV2_WT,36.5[CN111978395A] && 77[Lina Jia et al.£» 2021],,,,,,,,,,,,,,,,,,0.074nM[Lina Jia et al.£» 2021],,,,,,,,,,n.d.[CN111978395A] && 1.27nM[Lina Jia et al.£» 2021],14.67nM[Lina Jia et al.£» 2021],,,,CN111978395A (https://patents.google.com/patent/CN111978395A/en) && Lina Jia et al.£» 2021 (https://onlinelibrary.wiley.com/doi/full/10.1002/mco2.79),,Also known as MA1 in paper. Complete,Immunised Mouse,QVQLKESGPGLVAPSQSLSITCTVSGFSLSDYSISWIRQPPGKGLEWLGVIWGGGSTYYNSALKSRLSISKDNSKSQVELKMNSLQTDDTAMYYCAKHPLYYGSNSDGYYAMDYWGQGTSVTVSS,DIVMTQSHKFMSTSVGDRVSITCKASQDVGIVVAWYQQKPGQSPKLLIYWASTRHTGVPDRFTGSGSGTDFTLTISNVQSEDLADYFCQQYSSYPLTFGGGTKLEIK,IGHV2-6-5 (Mouse),IGHJ4 (Mouse),IGKV6-23 (Mouse),IGKJ1 (Mouse),AKHPLYYGSNSDGYYAMDY,QQYSSYPLT,ND
